Fengchao Zhao

5PUBLICATIONS
2CO-AUTHORS
Social epidemiologyHaematological tumoursNaturopathyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 25, 2025
Comparison of leg length discrepancy after total hip arthroplasty: Direct anterior and posterior lateral approach.

Yang Lu, Xiang Li, Yihe Hu

|Sep 23, 2023
Circular RNA circARPC1B functions as a stabilisation enhancer of Vimentin to prevent high cholesterol-induced articular cartilage degeneration.

Jiarui Li, Xiang Li, Shengji Zhou

|Nov 26, 2022
Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL.

Jiarui Li, Xiang Li, Shengji Zhou

|Sep 23, 2022
MCU Inhibitor Ruthenium Red Alleviates the Osteoclastogenesis and Ovariectomized Osteoporosis via Suppressing RANKL-Induced ROS Production and NFATc1 Activation through P38 MAPK Signaling Pathway.

Yuxin Wang, Xiang Li, Shengji Zhou

|Jan 10, 2021
Sclareol inhibits RANKL-induced osteoclastogenesis and promotes osteoblastogenesis through promoting CCN1 expression via repressing the MAPK pathway.

Xiang Li, Yuxin Wang, Liangping Li

Pageof 1

Frequent Collaborators

1 joint publications

Yuxin Wang

1 joint publications

Yang Lu